New Scalp Cooling Technology Shows Promise in Mitigating Chemotherapy-Induced hair Loss
Boston, MA – September 5, 2024 – A novel shampoo gel incorporating scalp cooling technology is poised to significantly reduce hair loss experienced by patients undergoing chemotherapy, according to recent findings. The innovation, detailed by GeneOnline News, offers a non-invasive approach to combatting a distressing side effect impacting quality of life for millions.Chemotherapy-induced alopecia affects a ample portion of cancer patients, frequently enough leading to psychological distress and body image issues. Current scalp cooling methods, typically involving refrigerated caps, can be cumbersome and expensive, limiting accessibility.This new gel aims to provide a more convenient and affordable solution by directly cooling the scalp during chemotherapy infusions. Researchers anticipate wider availability of the technology following further clinical trials and potential regulatory approvals, offering renewed hope for patients facing hair loss.
The technology centers around a specially formulated shampoo gel designed to lower scalp temperature. by constricting blood vessels,the cooling effect minimizes the amount of chemotherapy drug reaching hair follicles – the primary cause of hair loss. Preclinical studies have demonstrated a marked reduction in alopecia severity among test subjects.
“The goal is to protect the hair follicles from the toxic effects of chemotherapy without compromising treatment efficacy,” explained a researcher involved in the project, as reported by GeneOnline News. Further studies are underway to optimize the gel’s formulation and assess its long-term effects. The research team is currently recruiting participants for Phase II clinical trials, with results expected in late 2025.
